Since the last Annual Meeting, we have witnessed another dramatic wave of progress against cancer, from exciting basic science findings, to new drug approvals, expanded use of genomic data for precision medicine, and a greater focus on “big data” to accelerate progress in cancer research and in the clinic. Scientists are harnessing the power of mathematics, engineering, and artificial intelligence to diagnose cancer at an earlier stage. They are also concentrating their efforts on cancer in minorities and the medically underserved, working to eliminate the persistent disparities in cancer outcomes. All of these developments are reflected in the theme for the upcoming Annual Meeting: “Driving Innovative Cancer Science to Patient Care.” As we wind down our 110th Anniversary Year, this theme is a powerful reminder that at the heart of every scientific advance is a patient in urgent need of a cure.
All meeting information can be found here.